China NT Pharma Group Company Limited
1011.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$269.15M
Close$
Share Statistics
| Market cap | $269.15 Million |
|---|---|
| Enterprise Value | $592.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.04 |
| Beta | -1.99 |
| Outstanding Shares | 821,489,000 |
Return
| Return on Equity | 88.31% |
|---|---|
| Return on Assets | -15.28% |
| Return on Invested Capital | 772.28% |
Valuation & Multiples
| P/E Ratio | -9.8 |
|---|---|
| PEG | -130.25 |
| Price to Sales | - |
| Price to Book Ratio | -0.4 |
| Enterprise Value to Revenue | 10.93 |
| Enterprise Value to EBIT | -22.98 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.57 |
| Debt to Equity | -3.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China NT Pharma Group Company Limited
32 employees
CEO: Bozhi Zhang China NT Pharma Group Company Limited, operating alongside its various subsidiaries, is dedicated to the full spectrum of pharmaceutical activities. This encompasses the research, development, manufacturing, commercialization, and distri...